These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 27048879

  • 1. Immunization with a novel Clostridium perfringens epsilon toxin mutant rETX(Y196E)-C confers strong protection in mice.
    Yao W, Kang J, Kang L, Gao S, Yang H, Ji B, Li P, Liu J, Xin W, Wang J.
    Sci Rep; 2016 Apr 06; 6():24162. PubMed ID: 27048879
    [Abstract] [Full Text] [Related]

  • 2. Recombinant unpurified rETXH106P/ CTB-rETXY196E protects rabbits against Clostridium perfringens epsilon toxin.
    Peng X, Li X, Peng G, Feng L, Jiang Y, Luo Y.
    J Vet Med Sci; 2021 Apr 03; 83(3):441-446. PubMed ID: 33551442
    [Abstract] [Full Text] [Related]

  • 3. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
    Bokori-Brown M, Hall CA, Vance C, Fernandes da Costa SP, Savva CG, Naylor CE, Cole AR, Basak AK, Moss DS, Titball RW.
    Vaccine; 2014 May 13; 32(23):2682-7. PubMed ID: 24709588
    [Abstract] [Full Text] [Related]

  • 4. Amino acid residue Y196E substitution and C-terminal peptide synergistically alleviate the toxicity of Clostridium perfringens epsilon toxin.
    Yao W, Kang L, Gao S, Zhuang X, Zhang T, Yang H, Ji B, Xin W, Wang J.
    Toxicon; 2015 Jun 15; 100():46-52. PubMed ID: 25912943
    [Abstract] [Full Text] [Related]

  • 5. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
    Li Q, Xin W, Gao S, Kang L, Wang J.
    Hum Vaccin Immunother; 2013 Nov 15; 9(11):2386-92. PubMed ID: 23835363
    [Abstract] [Full Text] [Related]

  • 6. Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep.
    Jiang Z, Chang J, Wang F, Qi Y, Li Y, Yu D, Yu L.
    Vaccine; 2020 Sep 29; 38(42):6553-6561. PubMed ID: 32788135
    [Abstract] [Full Text] [Related]

  • 7. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
    Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, Kalapothakis E.
    Vaccine; 2010 Aug 31; 28(38):6125-7. PubMed ID: 20670910
    [Abstract] [Full Text] [Related]

  • 8. Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia.
    Mathur DD, Deshmukh S, Kaushik H, Garg LC.
    Appl Microbiol Biotechnol; 2010 Oct 31; 88(4):877-84. PubMed ID: 20676627
    [Abstract] [Full Text] [Related]

  • 9. PLGA Nanoparticle-Based Dissolving Microneedle Vaccine of Clostridium perfringens ε Toxin.
    Wan W, Li Y, Wang J, Jin Z, Xin W, Kang L, Wang J, Li X, Cao Y, Yang H, Wang J, Gao S.
    Toxins (Basel); 2023 Jul 19; 15(7):. PubMed ID: 37505730
    [Abstract] [Full Text] [Related]

  • 10. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U, Volkers P, Noeske K, Werner E.
    ALTEX; 2004 Jul 19; 21 Suppl 3():65-9. PubMed ID: 15057410
    [Abstract] [Full Text] [Related]

  • 11. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H, Neubauer A, Schlapp T, Wieler LH, Baljer G.
    Anaerobe; 2006 Feb 19; 12(1):44-8. PubMed ID: 16701610
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
    Kaushik H, Dixit A, Garg LC.
    Anaerobe; 2018 Oct 19; 53():50-55. PubMed ID: 29920342
    [Abstract] [Full Text] [Related]

  • 13. Antibody response to the epsilon toxin of Clostridium perfringens following vaccination of Lama glama crias.
    Bentancor AB, Halperin P, Flores M, Iribarren F.
    J Infect Dev Ctries; 2009 Sep 15; 3(8):624-7. PubMed ID: 19801806
    [Abstract] [Full Text] [Related]

  • 14. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis.
    Wang Y, Miao Y, Hu LP, Kai W, Zhu R.
    Mol Immunol; 2020 Jul 15; 123():88-96. PubMed ID: 32447084
    [Abstract] [Full Text] [Related]

  • 15. Clostridium perfringens epsilon prototoxin mutant rpETXY30A/Y71A/H106P/Y196A as a vaccine candidate against enterotoxemia.
    Du J, Wang T, Xu L, Wang C, Liu Y, Pan C, Chen X, Zhu Z, Luo Y, Yin C.
    Vaccine; 2023 Jul 19; 41(32):4762-4770. PubMed ID: 37357076
    [Abstract] [Full Text] [Related]

  • 16. Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization.
    Souza AM, Reis JK, Assis RA, Horta CC, Siqueira FF, Facchin S, Alvarenga ER, Castro CS, Salvarani FM, Silva RO, Pires PS, Contigli C, Lobato FC, Kalapothakis E.
    Genet Mol Res; 2010 Feb 18; 9(1):266-76. PubMed ID: 20198582
    [Abstract] [Full Text] [Related]

  • 17. A non-toxic recombinant bivalent chimeric protein rETXm3CSAm4/TMD as a potential vaccine candidate against enterotoxemia and braxy.
    Du J, Liu B, Wang T, Zhu Z, Yin C, Luo Y, Liu Y, Chen X.
    Vaccine; 2023 Feb 03; 41(6):1232-1238. PubMed ID: 36635138
    [Abstract] [Full Text] [Related]

  • 18. Expression of the alpha toxin of Clostridium perfringens in Lactobacillus casei genome and evaluation of its immune effects in mice.
    Song B, Cui H, Ju L, Song L, Tang L, Li Y.
    Microb Pathog; 2018 May 03; 118():1-8. PubMed ID: 29524545
    [Abstract] [Full Text] [Related]

  • 19. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, Sakurai J.
    Microbiol Immunol; 2013 May 03; 57(5):340-5. PubMed ID: 23668605
    [Abstract] [Full Text] [Related]

  • 20. Clostridium perfringens Epsilon Toxin Mutant I51C as a Recombinant Vaccine Candidate Against Enterotoxemia.
    Nakhaipour E, Kariminik A, Alimolaei M, Bafti MS.
    Clin Lab; 2024 Feb 01; 70(2):. PubMed ID: 38345990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.